Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Altucci

Showing results (321-330 of 358) with videos related to

Pageof 36
Sort By:
ACS Medicinal Chemistry Letters|September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
ACS Pharmacology & Translational Science|February 20, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis PatientsAnna Fontana, Laura Bergantini, Gabriele Carullo, et al.
European Journal of Medicinal Chemistry|September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modificationAnna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal CancerStefania Napolitano, Melanie Woods, Hey Min Lee, et al.
Cancers|January 1, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast CancerRosaria Benedetti, Carmela Dell'Aversana, Tommaso De Marchi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's DiseaseAngela De Simone, Valeria La Pietra, Nibal Betari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Editor's Note: RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of CancerVincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Aging Cell|November 18, 2025
Electron Microscopy and Multi-Omics Reveal Mitochondrial Dysfunction and Structural Remodeling in the Hearts of Elderly MiceManuela Giovanna Basilicata, Marco Malavolta, Serena Marcozzi, et al.
Cell Reports|November 17, 2016
Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune SystemsRonald P Schuyler, Angelika Merkel, Emanuele Raineri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of CancerVincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Pageof 36

Showing results (321-330 of 358) with videos related to

Sort By:
Pageof 36
ACS Medicinal Chemistry Letters|September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
ACS Pharmacology & Translational Science|February 20, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis PatientsAnna Fontana, Laura Bergantini, Gabriele Carullo, et al.
European Journal of Medicinal Chemistry|September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modificationAnna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2023
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal CancerStefania Napolitano, Melanie Woods, Hey Min Lee, et al.
Cancers|January 1, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast CancerRosaria Benedetti, Carmela Dell'Aversana, Tommaso De Marchi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's DiseaseAngela De Simone, Valeria La Pietra, Nibal Betari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Editor's Note: RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of CancerVincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Aging Cell|November 18, 2025
Electron Microscopy and Multi-Omics Reveal Mitochondrial Dysfunction and Structural Remodeling in the Hearts of Elderly MiceManuela Giovanna Basilicata, Marco Malavolta, Serena Marcozzi, et al.
Cell Reports|November 17, 2016
Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune SystemsRonald P Schuyler, Angelika Merkel, Emanuele Raineri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of CancerVincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Pageof 36